ArticleFrontiers in chemistry2026
Sensing of human stress biomarkers using BODIPY-functionalized carbon nanoparticles.
Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stress affects many aspects of human functioning, and its effects on cognition are particularly relevant in high performance scenarios such as military operations and space missions. Dopamine, noradrenaline, and cortisol are key biomarkers associated with stress, anxiety, depression, and cardiovascular disease, yet their qualitative and quantitative detection usually requires lengthy laboratory analyses and lacks a single, selective one-pot method. In this work, we developed a fluorescent nanosensor based on carbon nanoparticles functionalized with a BODIPY-based fluorophore (CNPs-Ar-BDPy) for the detection and discrimination of dopamine, noradrenaline, and cortisol in aqueous solution. The sensing platform exploits the carbon nanoparticle core as a structural scaffold and the BODIPY moiety as a recognition site, enabling specific interactions with catecholamines and cortisol through hydrogen bonding between the BODIPY fluorine atoms and the OH and C=O groups of the analytes. The CNPs-Ar-BDPy were synthesized, functionalized, and fully characterized by UV Vis and fluorescence spectroscopy, and their sensing performance was evaluated in aqueous media using fluorescent titration and FT-IR. Selectivity was further assessed using multivariate analysis by PLS-DA, demonstrating effective discrimination among the three biomarkers. In addition, the role of the covalent linkage between the carbon nanoparticle core and the BODIPY unit was investigated, and the obtained apparent affinity constants were compared with those of analogous nanoprobes featuring a non-rigid, non-preorganized spacer. The rigid aryl linked BODIPY proved to enhance binding by about two orders of magnitude, highlighting the importance of structural preorganization and fluorescence continuity across the core fluorophore interface. The proposed nanosensor thus represents a promising tool for rapid, selective monitoring of stress related biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.